BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23095029)

  • 41. Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase.
    Fourie AM
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1173-82. PubMed ID: 19876785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.
    Ye B; Bauman J; Chen M; Davey D; Khim SK; King B; Kirkland T; Kochanny M; Liang A; Lentz D; May K; Mendoza L; Phillips G; Selchau V; Schlyer S; Tseng JL; Wei RG; Ye H; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3891-4. PubMed ID: 18586492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of leukotriene A(4) hydrolase/aminopeptidase by sulfhydryl-blocking reagents: differential effects on dual enzyme activities by methyl-methane thiosulfonate.
    Orning L; Fitzpatrick FA
    Arch Biochem Biophys; 1999 Aug; 368(1):131-8. PubMed ID: 10415120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors.
    Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):442-6. PubMed ID: 19042128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Son M; Arulalapperumal V; Lee KW
    Future Med Chem; 2013 Jan; 5(1):27-40. PubMed ID: 23256811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Malecha JW; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1137-9. PubMed ID: 12643929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-based dissection of the active site chemistry of leukotriene A4 hydrolase: implications for M1 aminopeptidases and inhibitor design.
    Tholander F; Muroya A; Roques BP; Fournié-Zaluski MC; Thunnissen MM; Haeggström JZ
    Chem Biol; 2008 Sep; 15(9):920-9. PubMed ID: 18804029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase.
    Liang AM; Claret E; Ouled-Diaf J; Jean A; Vogel D; Light DR; Jones SW; Guilford WJ; Parkinson JF; Snider RM
    J Biomol Screen; 2007 Jun; 12(4):536-45. PubMed ID: 17384330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4529-32. PubMed ID: 18674901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leukotriene A4 hydrolase: a critical role of glutamic acid-296 for the binding of bestatin.
    Andberg M; Wetterholm A; Medina JF; Haeggström JZ
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):621-5. PubMed ID: 10642521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Sakkiah S; Lee KW
    Eur J Med Chem; 2011 May; 46(5):1593-603. PubMed ID: 21377770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme.
    Snelgrove RJ
    Thorax; 2011 Jun; 66(6):550-1. PubMed ID: 21502100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
    Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel structural and functional properties of leukotriene A4 hydrolase. Implications for the development of enzyme inhibitors.
    Haeggström JZ; Wetterholm A; Medina JF; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():3-12. PubMed ID: 7771344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.
    Jiang X; Zhou L; Wei D; Meng H; Liu Y; Lai L
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6549-52. PubMed ID: 18952425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema.
    De Oliveira EO; Wang K; Kong HS; Kim S; Miessau M; Snelgrove RJ; Shim YM; Paige M
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6746-50. PubMed ID: 21983441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and characterization of porcine skeletal muscle aminopeptidase T, a novel metallopeptidase homologous to leukotriene A4 hydrolase.
    Sarker MA; Matsuda S; Mizutani O; Rao S; Migita K; Goto-Yamamoto N; Iefuji H; Nishimura T
    Biosci Biotechnol Biochem; 2011; 75(6):1154-9. PubMed ID: 21670530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Wetterholm A; Macchia L; Haeggström JZ
    Arch Biochem Biophys; 1994 Jun; 311(2):263-71. PubMed ID: 8203889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
    Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
    J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.